- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04997655
The Effect of Upper Transabdominal Plain Block on Diaphragm Thickness
The Effect of Upper Transabdominal Plain Block on Diaphragm Thickness in Adult Patients After Laparoscopic Cholecystectomy Operation
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
The use of ultrasonography (USG) in operating rooms is increasing day by day. Diaphragm thickness can be evaluated by ultrasonography and is used as a bedside method studies have proven that the evaluation of diaphragmatic thickness contributes to the observation of diaphragmatic function and the evaluation of respiratory workload. Measurement of diaphragmatic thickness is a method used in operating rooms and intensive care units to make the decision to wean from mechanical ventilation and extubation. Laparoscopic gallbladder operations are a very common operation in the adult age group in the operating room. In these cases who were intubated and extubated at the end of the operation, regression in respiratory function is observed, especially due to right upper quadrant pain appropriate to the location of the liver. For this reason, the respiratory functions of patients who will have gallbladder surgery will be routinely evaluated before and after gallbladder surgery in our clinic with the help of USG and routinely apply analgesic methods, including peripheral nerve blocks, to patients with pain.
In this study, it will be planned to observe the effect of upper transabdominal area block, which is routinely performed post-operatively in laparoscopic gallbladder operations, on diaphragmatic thickness and therefore on respiratory capacity, and observationally evaluating diaphragmatic thickness measurements by USG, which is routinely performed post-operatively and the measurement records are noted.
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
Meram
-
Konya, Meram, Turkey, 42140
- Yasin Tire
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- Patients between the ages of 18-60
- Both sexes
- Patiets are evaluated as ASA 1 and ASA 2 anesthesia risk, will be examined.
Exclusion Criteria:
- Under 18 years old, over 60 years old
- BMI>35 kg/m2
- Bleeding diathesis
- Local anesthetic allergy
- Infection in the area of TAP (Trans abdominal plane) block application
- Illiteracy, communication problem
- Previous upper abdomen operation
- Transition to open surgery Cases
- Severe chronic respiratory disease
- Neuromuscular disorders.
Study Plan
How is the study designed?
Design Details
- Observational Models: Case-Control
- Time Perspectives: Prospective
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
Upper Transabdominal Plain Block
All patients in this group are routinely administered general anesthesia.
After extubation, the subcostal transverse abdominis area block was directed laterally along the rectus abdominis muscle by finding the linea alba under the xiphoid region under ultrasound guidance with a 22G echogenic block needle, and 20 ml (8 ml 0.5% bupivacaine, 7 ml prilocaine) into the fascia between the rectus abdominis and transverse abdominis muscles.
, 5 ml of saline) drug mixture will be performed by the anesthesiologist in charge of that day, who is not aware of the observational measurement to be made, if there is an indication, as a blind practitioner.
|
In the patient group who will undergo elective laparoscopic cholecystectomy, the diaphragmatic thickness values measured and recorded routinely at the pre-operative, post-extubation and post-operative 30th minute, at the end of inspiration and expiration, and the inspiratory amplitude in m-mode in the ultrasound measured from the right anterior axillary line subcostal area were observed as observational data.
will be saved in our file.
|
|
Opioid analgesia
All patients in this group are routinely administered general anesthesia.
Apart from this, in the other group, which does not have peripheral nerve block and only routine opioid analgesia is considered sufficient, only routine peroperative USG diaphragm measurements will be recorded observationally.
|
In the patient group who will undergo elective laparoscopic cholecystectomy, the diaphragmatic thickness values measured and recorded routinely at the pre-operative, post-extubation and post-operative 30th minute, at the end of inspiration and expiration, and the inspiratory amplitude in m-mode in the ultrasound measured from the right anterior axillary line subcostal area were observed as observational data.
will be saved in our file.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Diaphragm Thickness
Time Frame: 5 minutes before general anesthesia
|
The measurement of Diaphragm Thickness by USG
|
5 minutes before general anesthesia
|
|
Diaphragm Thickness
Time Frame: 5 minutes after surgery
|
The measurement of Diaphragm Thickness by USG
|
5 minutes after surgery
|
|
Diaphragm Thickness
Time Frame: 5 minutes after upper abdominal plane block
|
The measurement of Diaphragm Thickness by USG
|
5 minutes after upper abdominal plane block
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Oxygen saturation
Time Frame: Before the anesthesia, after anesthesia and after 30 minutes in the post operative care unit.
|
Oxygen saturation separately for each primary outcome stage
|
Before the anesthesia, after anesthesia and after 30 minutes in the post operative care unit.
|
|
Visual analogue scale
Time Frame: Before the anesthesia, after anesthesia and after 30 minutes in the post operative care unit.
|
The patient's pain will be asked in a scale from 1 to 10.
|
Before the anesthesia, after anesthesia and after 30 minutes in the post operative care unit.
|
Collaborators and Investigators
Sponsor
Investigators
- Study Director: Yasin Tire, Konya City Hospital
Publications and helpful links
General Publications
- Vivier E, Muller M, Putegnat JB, Steyer J, Barrau S, Boissier F, Bourdin G, Mekontso-Dessap A, Levrat A, Pommier C, Thille AW. Inability of Diaphragm Ultrasound to Predict Extubation Failure: A Multicenter Study. Chest. 2019 Jun;155(6):1131-1139. doi: 10.1016/j.chest.2019.03.004. Epub 2019 Mar 23.
- DiNino E, Gartman EJ, Sethi JM, McCool FD. Diaphragm ultrasound as a predictor of successful extubation from mechanical ventilation. Thorax. 2014 May;69(5):423-7. doi: 10.1136/thoraxjnl-2013-204111. Epub 2013 Dec 23.
- Dres M, Demoule A. Monitoring diaphragm function in the ICU. Curr Opin Crit Care. 2020 Feb;26(1):18-25. doi: 10.1097/MCC.0000000000000682.
Helpful Links
- Gülleroğlu, Aykan, et al. "Laparoskopik kolesistektomi operasyonlarında karın içi basınç artışının solunum mekaniği, hemodinami ve metabolizma üzerindeki etkileri." Ok Meydanı Eğitim ve Araştırma Hastanesi Anesteziyoloji ve Reanimasyon Kli
- Andıç, K. D., N. Göğüş, and Ayşe Lafcı. "Laparoskopik Kolesistektomi Geçiren Hastalarda Ultrasonografi Eşliğinde Uygulanan Transversus Abdominis Plan Bloğun Perioperatif Analjezi ve Hasta Konforuna Katkısı." (2021).
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- KonyaCityH
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.